MDIT OTC
Medite Cancer Diagnostics, Inc.
1W: +0.0%
1M: +0.0%
3M: +0.0%
YTD: +0.0%
1Y: +0.0%
3Y: -0.0%
5Y: -99.8%
$0.00
+0.00 (+0.00%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Cash Flow Trends
Operating Cash Flow
-$3M
-136.9% ▼
Capital Expenditures
$134K
-16.5% ▼
Free Cash Flow
-$3M
-125.5% ▼
Dividends Paid
$0
+0.0% ▲
Buybacks
$0
+0.0% ▲
Net Change in Cash
$382K
+175.5% ▲
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2015 | FY2016 | FY2017 |
|---|---|---|---|
| — Operating Activities — | |||
| Net Income | -$859K | -$2M | -$7M |
| Depreciation & Amort. | -$177K | $214K | $293K |
| Stock-Based Comp. | $0 | $0 | $0 |
| Change in Working Capital | $216K | $129K | $2M |
| Other Non-Cash Items | $0 | $1M | $191K |
| Operating Cash Flow | -$388K | -$1M | -$3M |
| — Investing Activities — | |||
| Capital Expenditures | -$354K | -$115K | -$134K |
| Acquisitions (Net) | $0 | $0 | $0 |
| Investment Purchases | $0 | $0 | $0 |
| Investment Sales | $0 | $0 | $0 |
| Other Investing | $0 | $0 | $0 |
| Investing Cash Flow | -$354K | -$115K | -$134K |
| — Financing Activities — | |||
| Net Debt Issuance | -$302K | $213K | $2M |
| Stock Repurchased | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 |
| Other Financing | -$40K | $106K | -$422K |
| Financing Cash Flow | $2M | $700K | $4M |
| Net Change in Cash | $970K | -$506K | $382K |
| Cash End of Period | $970K | $108K | $490K |
| Free Cash Flow | -$742K | -$1M | -$3M |